The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...

The decision means many Americans without underlying conditions may not have access to updated shots this fall."I think we ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...

In a major policy shift, federal health officials anticipate the shots will be made available to adults 65 and older as well ...

Agency will ask drugmakers for large trials for new versions of vaccines meant for healthy adults and children.

"Here is a prime example of just how influential Big Pharma still is," MAHA influencer Diana Atieh told Newsweek.

In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.